Constellation Brands, IncNYSE: STZ
Consumer Staples · Distillers & Vintners
$153.08
-2.24%
Vol: 2.0M
Research Digest
Friday, May 1, 2026
Constellation Brands withdraws 2028 guidance; appoints Nicholas Fink as new CEO
Constellation Brands withdrew 2028 guidance and reported subdued demand across categories in Q4 2025, though beat Wall Street estimates. New CEO Nicholas Fink assumes role; Jim Bourdeau retiring with Jeff LaBarge named Chief Legal Officer successor. Company is focusing Pacifico growth strategy for 2027 with World Cup marketing campaigns. Acquired remaining HOPWTR interest. TD Cowen upgraded to Buy with $190 PT.
Previous Market Intelligence
13 daysApr 30Constellation Brands appoints Nicholas Fink as CEO effective April 13; Q4 2026 EPS of $1.90 beats $1.72 estimate but FY2027 guidance disappoints.Negative▶
Constellation Brands reported fiscal year and Q4 2026 results on April 8 with EPS of $1.90 versus $1.72 expected and revenue of $1.92B versus $1.88B expected. Q4 net income improved to $224.7M from a $370.6M loss a year prior. The company appointed Nicholas Fink as new CEO effective April 13, replacing Bill Newlands. Management withdrew its previously issued FY2028 outlook and guided FY2027 adjusted EPS of $11.20-$11.90 versus $12.36 estimates. Management cited deliberate consumer spending behavior and subdued demand across categories. FY2026 sales declined 10% organically with beer down 3% and wine/spirits down 14%.
Apr 29Constellation Brands receives TD Cowen upgrade to Buy with $190 price target amid beer segment stabilizationPositive▶
Constellation Brands gained attention after TD Cowen upgraded its rating to Buy with new price target of $190. Company shows signs of stabilization in its beer segment following earnings reports and strong cash flow. Teachers Retirement System of Kentucky raised its stake by 129.6% in the fourth quarter. Corona brand unveiled seasonal MLB marketing campaign. Current price $154.17 represents potential 23% upside to median analyst target of $175.
Apr 16Constellation Brands reports Q4 earnings beat but withdraws 2028 guidance citing subdued demand; new CEO assumes role April 13Mixed▶
Constellation Brands reported Q1 fiscal year earnings that beat analyst expectations but revealed material headwinds. The company reported revenues of $1.92 billion (down 11.3% YoY) but exceeded expectations by 2.3%. Beer segment achieved 6% net sales growth with Modelo Especial advancing nearly 5%, though Corona Extra declined 3%. The company withdrew previously issued fiscal 2028 guidance due to subdued demand and reduced fiscal 2027 EPS guidance to $11.20-$11.90 from consensus of $12.36. New CEO Nicholas Fink assumed the role April 13. The company completed a $999 million buyback and announced a $1.03 quarterly dividend. Multiple analyst price targets were raised despite challenging demand environment.
Apr 15Constellation Brands surges 8.5% after Q4 2026 earnings beat and new CEO Nicholas Fink appointment effective April 13.Positive▶
Constellation Brands reported Q4 2026 EPS of $1.90 (beat estimate of $1.72) on revenue of $1.92 billion (beat $1.88B estimate). The company appointed Nicholas Fink as its new CEO effective April 13. Beer brands showed strong growth: Pacifico depletions jumped 21% and Victoria grew 17%. Constellation is nearing completion of a $1.3 billion Veracruz brewery in Mexico. Shares surged 8.5% on April 10.
Apr 14Constellation Brands reported Q4 earnings beat but withdrew fiscal 2028 guidance due to subdued demand; new CEO Nicholas Fink took office April 13.Negative▶
Constellation Brands beat Q4 revenue with EPS of $1.90 versus consensus $1.74, but withdrew fiscal 2028 guidance citing subdued consumer spending. Fiscal 2027 EPS guidance of $11.20-11.90 trails estimates. New CEO Nicholas Fink commenced April 13. Wells Fargo raised target to $180 with Overweight rating.
Apr 13Constellation Brands withdrew 2028 guidance citing subdued demand and issued cautious 2027 EPS outlook of $11.20-$11.90, below consensus $12.36.Negative▶
STZ Q4 earnings beat with $1.90 EPS vs. $1.74 consensus but withdrew 2028 guidance. 2027 EPS guidance of $11.20-$11.90 trails $12.36 consensus reflecting subdued demand across beer categories. CEO Nicholas Fink taking role April 13. Stock up 17.7% YTD despite 28% YoY EPS decline. Wells Fargo raised price target to $180 from $165, Citi upgraded to Buy from Neutral.
Apr 10Constellation Brands Q4 earnings beat; withdraws FY2028 outlook; new CEOMixed▶
Q4 2026 earnings beat with $1.90 adjusted EPS vs $1.72 estimate. Withdrew FY2028 outlook. New CEO Nicholas Fink assumes role April 13.
Apr 9Constellation Brands Withdraws FY2028 Guidance, Reports Subdued Demand Across CategoriesNegative▶
Constellation Brands withdrew its previously issued fiscal 2028 outlook on April 8, 2026, reporting subdued demand across alcohol categories amid economic uncertainty. The company still beat analyst estimates for Q4 2026, with comparable net sales down 4% to $9,139 million and adjusted EPS down 14% to $11.82. For fiscal 2027, the company expects adjusted EPS of $11.20 to $11.90 versus $12.36 consensus. The company appointed Nicholas Fink as new CEO, effective April 13. Consumer spending behavior became more deliberate due to broader economic uncertainty.
Apr 8Constellation Brands reports Q4 earnings April 8 with UBS raising target to $176.Positive▶
Constellation Brands reported Q4 fiscal 2026 earnings April 8. UBS raised PT to $176 with Buy. Analysts expect EPS $1.71 on revenue $1.87B; revenues expected to decline 13% YoY.
Apr 7Constellation Brands reports Q4 earnings tomorrow with CEO transition underwayPositive▶
Constellation Brands will report Q4 fiscal 2026 earnings on April 8, 2026. Analysts expect EPS of $1.71 (up 35% YoY) on revenue of $1.87B (down 13% YoY). Options traders expect ±5.6% stock move post-earnings. Stock has gained 10% YTD supported by strong Modelo and Pacifico brand demand. UBS analyst Peter Grom raised target to $176 from $168 (Buy); Roth Capital maintains Buy rating with $209 target. CEO transition occurring with Nicholas Fink succeeding Bill Newlands. Analyst consensus: Moderate Buy with 11.77% upside from $169 average target.
Apr 6Constellation Brands added to Evercore ISI Tactical Outperform list ahead of April 8 earnings.Positive▶
Constellation Brands received boost from Evercore ISI, added to Tactical Outperform list with $170 price target ahead of April 8 full-year earnings release. Firm cites likely top-line upside driving bottom-line leverage. Company beat earnings in three of last four quarters (7%-16% surprises). Fortress beer margins at 38%, trades at 12x forward P/E vs 13x consensus. Stock at $151.17. CEO transition and softer beer growth signals temper enthusiasm from other analysts.
Apr 3Constellation Brands appoints Nicholas Fink as new President and CEO effective April 13, 2026, with Q4 earnings due April 8.Positive▶
Constellation Brands announced Nicholas Fink as President and CEO effective April 13, 2026. Q4 fiscal 2026 results scheduled for April 8. Consensus estimates project fiscal Q4 EPS of $1.73 (down 34.2% YoY). Evercore ISI added Constellation to Tactical Outperform list with $170 target. Needham reaffirmed Buy with $180 target.
Apr 2UBS raises Constellation Brands target to $176; Deutsche Bank cuts to $154 amid margin pressures and Hop Wtr acquisitionMixed▶
Constellation Brands completed acquisition of Hop Wtr, a US hop-infused sparkling water with adaptogens, reinforcing presence in no- and low-alcohol wellness segment aligned with consumer moderation trends. UBS raised price target from $168 to $176 with Buy rating; Deutsche Bank lowered target from $162 to $154 with Hold rating. Analysts cite margin pressures on core beer business and softer organic growth raising concerns about profitability conversion, though Q1 2026 EPS beat guidance at $3.06 vs $2.63 consensus.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| STZCONSTELLATION | $153.08 | -2.24% | +0.9% | 12.6x | 0.43 | $27.0B |
| BF.BBROWN | $25.58 | -0.74% | -3.6% | 15.2x | 0.42 | $11.8B |
| WMTWALMART | $131.84 | -0.07% | +4.0% | 40.2x | 0.66 | $1.05T |
| COSTCOSTCO | $1,012.70 | -0.18% | -0.4% | 45.1x | 0.98 | $450.1B |
| PGPROCTER | $147.58 | +0.33% | +3.0% | 20.7x | 0.40 | $342.5B |
| KOCOCA | $78.69 | -0.10% | +2.0% | 22.7x | 0.36 | $338.9B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price between 50d and 200d. Testing 50d support.